EXPERT SPEAKER FACULTY

2024 Speakers - 7th Annual TPD & Induced Proximity Summit

Abhishek Dogra

Director - Medicinal Chemistry & Induced Proximity

A-Alpha Bio

Adrian Gottschalk

CEO

Foghorn Therapeutics

Alessio Ciulli

Founder & Director - Centre Targeted Protein Degradation, Professor - Chemical & Structural Biology

University of Dundee

Amine Sadok

Director, Induced Proximity Platform

Amgen

Andreas Reichel

Vice President, Head Of DMPK Modelling & Simulations

Bayer

Andrew Hirsch

CEO

C4 Therapeutics

Andrew Tsourkas

Professor

University of Pennsylvania

Anita Bellail

CSO and COO

HB Therapeutics

Ankit Sharma

Associate Director, Medicinal Chemistry, Oncology Targeted Discovery

AstraZeneca

Arnout Schepers

Founder & Chief Executive Officer

TenAces Biosciences

Arthur T. Sands

Chief Executive Officer

Nurix Therapeutics

Arvind Shakya

Director

BioTheryx

Barbara Lueckel

Global Head, Research Technologies Partnering

F. Hoffmann-La Roche

Benedict Cross

Chief Technology Officer & Head of Platform

Phoremost

Bernd Boidol

CEO

Proxygen

Bradlee Heckmann

Chief Scientific Officer

Asha Therapeutics

Carolyn Porter

Chief Executive Officer

Outrun Therapeutics

Charu Chaudhry

Senior Principal Scientist

Johnson & Johnson Innovative Medicine

Chinatsu Sakata-Sakur

Vice President

Astellas Pharma

Christian Dillon

Chief Scientific Officer

PhoreMost

Christian Ottmann

Associate Professor

Eindhoven University of Technology

Christina Woo

Associate Professor

Harvard University

Dan Finley

Professor

Harvard Medical School

Diogo Feleciano

Co-Founder and COO

Booster Therapeutics

Dmitri Ivanov

Associate Professor

UT Health San Antonio

Effie Tozzo

Chief Scientific Officer

Avilar Therapeutics

Elena De Vita

Assistant Professor

Queen Mary University of London

Elizabeth Caine

Scientist

Promega

Eric Fischer

Professor

Harvard Medical School

Eugene Chekler

Scientific Director, Head of Chemistry at Redwood City site

Bristol Myers Squibb

Gang Yao

Associate Director

GSK

Gary Kleiger

Chair & Professor

University of Las Vegas Nevada

Giovanni Spagnolli

Co-Founder & Chief Technology Officer

Sibylla Biotech

Gisele Nishiguchi

Lead Scientist

St. Jude Children's Research Hospital

Greg Michaud

Director

Novartis AG

Hailong Zhang

Chief Executive Officer

Blueray Biopharma

Henrik Daub

Founder & Chief Scientific Officer

NEOsphere Biotechnologies

Ian Churcher

Chief Executive Officer

Janus Drug Discovery

Jaehyun Choi

Co-founder, Chief Executive Officer

EPD Biotherapeutics

James Papatzimas

Principal Scientist

Novartis

Jason Kantor

Chief Business Officer

Nurix Therapeutics

Jessica Sims

Principal Scientist Toxicology

Genentech

JF Brazeau

Director

Plexium

Jian Jin

Mount Sinai Endowed Professor

Icahn School of Medicine at Mount Sinai

Joachim Rudolph

Senior Fellow Discovery Chemistry

Genentech

Johan Johansson

Associate Principal Scientist, CVRM PROTAC Lead, Project Leader

AstraZeneca

John Houston

Chairman, CEO & President

Arvinas

Juliet Williams

Head of Research

Kymera Therapeutics

Kanak Raina

Sr. Director, Head of Biology

Halda Therapeutics

Karteek Kadimisetty

Director

LifeSensors

Kelly Rainbolt

Senior Scientist - Biochemical & Cellular Engineering

Lyterian Therapeutics

Ken Yamada

Associate Director

Novartis

Keunsoo Kang

Chief Scientific Officer

Deargen

Kylie Walters

Senior Investigator and Section Chief

National Institutes of Health

Len Reyno

Chief Medical Officer

C4 Therapeutics

Leo Fu

Co-Founder & Chief Technology Officer

GluBio Therapeutics

Lise Loberg

Preclinical Safety Expert

AbbVie

Magnus Walter

Senior Vice President Drug Discovery

Monte Rosa Therapeutics

Mark Niosi

Principal Scientist

Pfizer

Matthias Brand

Co-Founder & Chief Scientific Officer

Proxygen

Maureen Galmes-Spit

VP Research

Laigo Bio

Nadeem Vellore

Principal Scientist

Johnson & Johnson

Nan Ji

Co- Founder, President & Chief Executive Officer

PAQ Therapeutics

Natalie Nairn

Cofounder and CEO

Cyclera Therapeutics

Neil Bence

Vice President, Oncology Discovery

Bristol Myers Squibb

Nello Mainolfi

Chief Executive Officer

Kymera Therapeutics

Pat Sharp

Co-founder and Vice President

Gate Bioscience

Paula O’Connor

Chief Medical Officer

Nurix Therapeutics

Peggy Scherle

Chief Scientific Officer

Prelude Therapeutics

Radoslav Enchev

Group Leader

The Francis Crick Institute

Raegan O’Lone

Senior Program Advisor

HESI

Randolph Lopez

Co-Founder & Chief Technology Officer

A-Alpha Bio

Randy Teel

CBO

Arvinas

Riccardo Sabatini

Chief Data Scientist

Orionis Biosciences

Rick Ewing

VP Head of Chemistry

Rapafusyn

Ryan Kerrigan

Principal Scientist II

Novartis

Sarah Carratt

Principal Scientist

Pfizer

Scott Boyle

Chief Business Officer

C4 Therapeutics

Sharon Townson

Chief Scientific Officer

Monte Rosa Therapeutics

Shyra Gardai

Chief Scientific Officer

EpiBiologics

Stephanie Leuenroth-Quinn

Associate Director for Pharmacology and Toxicology

FDA

Steven Banik

Assistant Professor

Stanford University

Steven Bellon

Chief Scientific Officer

Foghorn Therapeutics

Stewart Fisher

Chief Scientific Officer

C4 Therapeutics

Stuart Schreiber

Founding Chief Executive Officer

Arena Bioworks

William Housley

Principal Research Scientist

Abbvie

Wu Du

Senior Vice President Medicinal Chemistry

Hinova Pharmaceuticals

Xiaoran Han

Vice President, Discovery Medicine

Cullgen

Ya-Wen Lu

Associate Director

Nurix Therapeutics

Yao Wang

Chief Medical Officer

Kangpu Biopharmaceuticals

Yong Cang

Co-Founder & Chief Scientific Officer

Degron Therapeutics

Zoran Rankovic

Director, Centre for Protein Degradation

The Institute for Cancer Research

FULL EVENT GUIDE
REGISTER
PARTNER